| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Peter Beetham | Interim CEO Pres COO | 2026-03-30 | 16,112 | $1.85 | $29.81kSell |
| Carlo Broos | CFO | 2026-03-30 | 3,676 | $1.87 | $6.87kSell |
| Gregory Francis William Gocal | Chief Scientific Officer EVP | 2026-03-30 | 8,954 | $1.82 | $16.30kSell |
| Noel Sauer | Sr VP Research | 2026-03-30 | 1,763 | $1.84 | $3.24kSell |
| Jason Stokes | CLO Gen Csl Secy | 2026-03-30 | 3,695 | $1.83 | $6.76kSell |
| Jason Stokes | CLO Gen Csl Secy | 2026-02-19 | 4,795 | $2.98 | $14.29kSell |
| Rory B. Riggs | Director | 2026-01-29 | 333,333 | $1.50 | $500.00kBuy |
| Jeanpierre Jules Lehmann | Director | 2026-01-29 | 666,666 | $1.50 | $1,000.00kBuy |
| Noel Sauer | Sr VP Research | 2025-11-11 | 1,834 | $1.32 | $2.42kSell |
| Carlo Broos | CFO | 2025-11-11 | 1,496 | $1.32 | $1.97kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sa Cellectis | 31.35% | 23,963,175 | $42.41M | Insider |
| Rory B. Riggs | 21.07% | 16,100,884 | $28.50M | Insider |
| Jeanpierre Jules Lehmann | 3.21% | 2,450,975 | $4.34M | Insider |
| Mark Terrence Finn | 2.02% | 1,544,711 | $2.73M | Insider |
| Jonathan Finn | 1.99% | 1,519,221 | $2.69M | Insider |
| Craig Wichner | 1.17% | 894,309 | $1.58M | Insider |
| Peter Beetham | 0.90% | 686,825 | $1.22M | Insider |
| Gregory Francis William Gocal | 0.55% | 422,890 | $748.52k | Insider |
| James Blome | 0.24% | 186,282 | $329.72k | Insider |
| Federico A. Tripodi | 0.24% | 181,300 | $320.90k | Insider |